Loss of both diffusion restriction and arterial enhancement can predict complete pathological response following Y-90 selective internal radiation therapy for hepatocellular carcinoma
The combination of mRECIST CR when combined with loss of diffusion restriction appears to predict CPN post SIRT; persistent diffusion restriction despite the findings of mRECIST CR appears to correlate with residual disease.
Authors
- William E. L. Ormiston (ORCID: https://orcid.org/0000-0002-7333-6029)
- M. Ballal
- Kenneth Ngo (ORCID: https://orcid.org/0000-0001-5511-2825)
- M. Christopher Wallace (ORCID: https://orcid.org/0000-0002-2024-9677)
- Kah Heng Alexander Lim (ORCID: https://orcid.org/0000-0002-1652-7347)
- Tze Sheng Khor (ORCID: https://orcid.org/0000-0003-0236-3342)
- Jonathan M. Tibballs (ORCID: https://orcid.org/0000-0001-6562-3434)
- Mayank Bhandari
- Matthew Joel Clifford
- Lingjun Mou
- Luc Delriviere
Institutions
- The University of Western Australia (AU)
- Curtin University (AU)
- Fiona Stanley Hospital (AU)
- Sir Charles Gairdner Hospital (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- Abdominal Radiology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1007/s00261-026-05377-5
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Notre Dame